No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition

A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence New System Rounds Out CT Portfolio that Provides Clinicians with Innovative Cardiac Capabilities

Editor: What To Know

  • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and Power Save Mode improvements that enable the Aquilion ONE GENESIS / SP to require less cost to operate.
  • is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete CT solution with proven cardiovascular capabilities.
  • Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process — from evaluation to treatment, offering a wide range of features for complete cardiac care, including innovative CT technologies such as.

Canon Medical notes to meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete CT solution with proven cardiovascular capabilities. The Aquilion ONE / GENESIS SP was designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its AI-powered wide-area CT.

Canon Medical reports the Aquilion ONE / GENESIS SP enhances Canon Medical’s suite of Collaborative imaging tools which deliver clarity and confidence across the patient care cycle. Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process — from evaluation to treatment, offering a wide range of features for complete cardiac care, including innovative CT technologies such as:

  • Improved diagnostic confidence across patients with one-beat, whole-heart acquisition and Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), which enables clinicians to obtain sharp, clear and distinct images.
  • Enhanced workflow capabilities because of automated tools from acquisition through analysis such as SURECardio and Vitrea Advanced Visualization, which can help clinicians manage their new increase in patient volume, and also deliver proven consistency in high image quality.
  • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and Power Save Mode improvements that enable the Aquilion ONE GENESIS / SP to require less cost to operate.
  • Patient-centric enhancements to help improve safety, comfort and access, including a wide bore (78 cm) and wide (47 cm) and low (33 cm) couch.

“Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. At Canon Medical, we are committed to providing technologies that help clinicians keep pace with these evolving clinical pathways,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Canon Medical’s CT product line, including the Aquilion ONE / GENESIS SP, is designed to offer complete cardiac capabilities. The platform was designed to be intuitive, making the acquisition of high-quality images easy and reliable across the full spectrum of patients and clinical scenarios.”

Canon Medical is showcasing the all-new Aquilion ONE / GENESIS SP and its full suite of innovative cardiac capabilities for high-quality routine cardiac imaging at this year’s virtual Society of Cardiac Computed Tomography (SCCT) annual meeting. Visit the booth here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy